CLASS II Device recall · Reported 5 Jun 2013 · FDA Enforcement Report

RayStation Therapy Treatment Planning System recalled

Raysearch Laboratories AB is recalling RayStation Therapy Treatment Planning System, distributed in Connecticut, Florida, Massachusetts, Missouri, New York, Ohio. The recall was initiated on 15 Feb 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware version and build numbers 2.0.0.15, 2.5.1.89, and 3.0.0.251 (to determine if the version used is affected, bring up the About box in the RayStation application and check the build number reported0.
Quantity recalledDomestic: 70 units; Foreign: 27 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1419-2013
FDA event ID
65136
Recalling firm
Raysearch Laboratories AB, Stockholm, N/A
Classification
Class II
Status
Terminated
Recall initiated
15 Feb 2013
FDA classified
28 May 2013
Reported
5 Jun 2013
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

15 Feb 2013Recall initiated by company
28 May 2013Classified by FDA+102 days
5 Jun 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Under some circumstances, imported CT, MR and PET images are offset from their true positions by one pixel in one or two directions. Users must be aware of this information to avoid incorrect dose calculations during treatment planning.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RayStation Therapy Treatment Planning System, Model Numbers 2.0, 2.5, and 3.0; CLASSIFICATION NAME: System, Planning, Radiation Therapy Treatment. RayStation is a software system designed for treatment planning and analysis of radiation therapy.

Where it was distributed

Worldwide Distribution - USA including Connecticut, Florida, Massachusetts, Missouri, New York, Ohio, and foreign distribution to(Canada, Italy, Australia, Germany, Netherlands, and Switzerland.

ConnecticutFloridaMassachusettsMissouriNew YorkOhio

Questions about this recall

Why was it recalled?

Under some circumstances, imported CT, MR and PET images are offset from their true positions by one pixel in one or two directions. Users must be aware of this information to avoid incorrect dose calculations during treatment planning.

Which lots are affected?

Software version and build numbers 2.0.0.15, 2.5.1.89, and 3.0.0.251 (to determine if the version used is affected, bring up the About box in the RayStation application and check the build number reported0.

Where was it sold?

Worldwide Distribution - USA including Connecticut, Florida, Massachusetts, Missouri, New York, Ohio, and foreign distribution to(Canada, Italy, Australia, Germany, Netherlands, and Switzerland.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories AB

All 115

Other Medical Software recalls

All 903